F
Falko Fend
Researcher at University of Tübingen
Publications - 448
Citations - 13892
Falko Fend is an academic researcher from University of Tübingen. The author has contributed to research in topics: Medicine & Lymphoma. The author has an hindex of 55, co-authored 380 publications receiving 11218 citations. Previous affiliations of Falko Fend include German Cancer Research Center & Technische Universität München.
Papers
More filters
Journal ArticleDOI
T-helper-1-cell cytokines drive cancer into senescence
Heidi Braumüller,Thomas Wieder,Ellen Brenner,Sonja Aßmann,Matthias Hahn,Mohammed Alkhaled,Karin Schilbach,Frank Essmann,Manfred Kneilling,Christoph M. Griessinger,Felicia Ranta,Susanne Ullrich,Ralph Mocikat,Kilian Braungart,Tarun Mehra,Birgit Fehrenbacher,Julia Berdel,Heike Niessner,Friedegund Meier,Maries van den Broek,Hans-Ulrich Häring,Rupert Handgretinger,Leticia Quintanilla-Martinez,Falko Fend,Marina Pesic,Jürgen Bauer,Lars Zender,Martin Schaller,Klaus Schulze-Osthoff,Martin Röcken +29 more
TL;DR: The combined action of the T-helper-1-cell cytokines IFN-γ and tumour necrosis factor (TNF) directly induces permanent growth arrest in cancers, a general mechanism for arresting cancer progression.
Journal ArticleDOI
Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans.
Natalia S. Pellegata,Leticia Quintanilla-Martinez,Heide Siggelkow,Elenore Samson,Karin Bink,Heinz Höfler,Falko Fend,Jochen Graw,Michael J. Atkinson +8 more
TL;DR: The findings demonstrate that germ-line mutations in p27Kip1 can predispose to the development of multiple endocrine tumors in both rats and humans.
Journal ArticleDOI
The International Consensus Classification of Mature Lymphoid Neoplasms: A Report from the Clinical Advisory Committee.
Elias Campo,Elaine S. Jaffe,James R. Cook,Leticia Quintanilla-Martinez,Steven H. Swerdlow,Kenneth C. Anderson,Pierre Brousset,Lorenzo Cerroni,Laurence de Leval,Stephan Dirnhofer,Ahmet Dogan,Andrew L. Feldman,Falko Fend,Jonathan W. Friedberg,Philippe Gaulard,Paolo Ghia,Steven M. Horwitz,Rebecca L. King,Gilles Salles,Jesús F. San Miguel,John F. Seymour,Steven P. Treon,Julie M. Vose,E. Zucca,Ranjana H. Advani,Stephen M. Ansell,Wing Yan Au,Carlos Barrionuevo,P. Leif Bergsagel,Wing C. Chan,Jeffrey I. Cohen,Andrew Davies,Brunangelo Falini,Irene M. Ghobrial,John R. Goodlad,John G. Gribben,Eric D. Hsi,Brad S. Kahl,Won Seog Kim,Shaji Kumar,Ann S. LaCasce,Camille Laurent,Georg Lenz,John J. Leonard,Michael P. Link,Armando López-Guillermo,Maria-Victoria Mateos,Elizabeth Macintyre,Ari Melnick,Franck Morschhauser,Shigeo Nakamura,Marina Narbaitz,Astrid Pavlovsky,Stefano Pileri,Miguel A. Piris,Barbara Pro,S. Vincent Rajkumar,Steve Rozen,Birgit Sander,Laurie H. Sehn,Margaret A. Shipp,Sonali M. Smith,Louis M. Staudt,Catherine Thieblemont,Thomas Tousseyn,Wyndham H. Wilson,Tadashi Yoshino,Pier Luigi Zinzani,Martin Dreyling,David Scott,Jane N. Winter,Andrew D. Zelenetz +71 more
TL;DR: The definition, recommended studies, and criteria for the diagnosis of many entities have been extensively refined and some categories considered provisional are now upgraded to definite entities in the proposed International Consensus Classification of mature lymphoid, histiocytic, and dendritic cell tumors.
Journal ArticleDOI
Laser capture microdissection in pathology
Falko Fend,Mark Raffeld +1 more
TL;DR: Laser capture microdissection (LCM) is state-of-the-art technology that provides the scientific community with a rapid and reliable method to isolate a homogeneous population of cells from heterogeneous tissue specimens, thus providing investigators with the ability to analyze DNA, RNA, and protein accurately from pure populations of cells.
Journal ArticleDOI
Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma
Martina Rudelius,Stefania Pittaluga,Satoshi Nishizuka,Trinh Hoc Tran Pham,Falko Fend,Elaine S. Jaffe,Leticia Quintanilla-Martinez,Mark Raffeld +7 more
TL;DR: It is concluded that constitutive activation of the PI3K/Akt pathway contributes to the pathogenesis of MCL and preferentially occurs in blastoid variants and one possible mechanism of activation is loss of PTEN expression.